You are here

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Shenyang, Liaoning, 110016 China
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Smoking Cessation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Current cigarette smokers between the ages of 18 and 75 years, who are motivated to
stop smoking

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients currently suffering from depression, or have been diagnosed with depression
in the last 12 months, or subjects with past or present history of psychosis, panic
disorder, or bipolar disorder

- Any subject with known severe chronic obstructive pulmonary disease (COPD)

NCT00371813
Pfizer
Completed
An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now